Clinical Trials Logo

Pelvic Organ Prolapse clinical trials

View clinical trials related to Pelvic Organ Prolapse.

Filter by:

NCT ID: NCT02190825 Completed - Clinical trials for Pelvic Organ Prolapse

Safety and Efficacy Study of the NeuGuide Device

Start date: November 2014
Phase: N/A
Study type: Interventional

This study aims to investigate the safety, efficacy, peri and postoperative complications, and patient satisfaction of sacro-spinous ligament fixation (SSLF) for the management of pelvic organ prolapse (POP). Prolapse staging for all subjects in this study will be performed according to the POP-Q staging system. Ultrasound examinations for all subjects in this study are subjected to the surgeon need and will be performed if required by qualified personnel

NCT ID: NCT02189291 Completed - Clinical trials for Pelvic Organ Prolapse

Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy

CARESS
Start date: July 2014
Phase: N/A
Study type: Interventional

Objectives The objective of this study is to help identify the best practice regarding the use of indwelling catheter after minimally invasive urogynecologic surgery. Investigators propose a randomized controlled trial comparing the immediate removal of indwelling urethral catheter, after minimally invasive sacrocolpopexy, to the present standard catheter removal on post operative day one. Evidence based catheter management will be helpful to both providers and patients in post-operative decision making. Specific Aims Aim 1: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy results in shorter hospital stay than removal on postoperative day 1. Aim 2: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy confers no increased risk of re-catheterization. Aim 3: To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy decreases the occurrence of urinary tract infection. Design A randomized controlled trial comparing the standard overnight indwelling urethral catheterization with removal of catheter immediately post surgery after minimally invasive sacrocolpopexy, at Oregon Health & Science University. Outcome measures Primary outcome measures are hospital stay in hours after completion of surgery and need for re-catheterization. Hospital stay will be counted from the time the patient leaves the operating room to the time she leaves the hospital. To avoid confounding, investigators are only including the first / morning case of the day. For re-catheterization, investigators will evaluate if patient was able to void after completion of surgery. Investigators will compare the post voiding residuals, the need for re-catheterizations and the numbers of patients going home with an indwelling catheter between the two groups. Investigators will also compare the number of urinary tract infections, as documented by urine culture and subsequent treatment, between the two groups. Study Subjects Study subjects will be women undergoing minimally invasive sacrocolpopexy. Women will be invited to participate in the study during their preoperative visit. If they agree to participation, this will be noted in their chart. Randomization to group will occur immediately following surgery.

NCT ID: NCT02185235 Recruiting - Clinical trials for Pelvic Organ Prolapse

A Randomized Controlled Trial of Electrical Stimulation to Treat Pelvic Floor Disorder

Start date: June 2014
Phase: N/A
Study type: Interventional

Female pelvic floor disorders (PFDs) include urinary incontinence,pelvic organ prolapse (POP), and fecal incontinence-which often occur together. Pelvic floor disorders impair multiple aspects of the life quality, including the sexual function of women. Surgery became the first choice of treatment, however, and not until 1980s was the renewed interest in conservative therapies. This may be because of higher awareness among women and cost of and morbidity after surgery. The conservative treatment included pelvic floor muscle training, electrical stimulation, vaginal cones, and biofeedback. The outcome was up to 35~70 % improved rate as the literature before. Current guidelines recommended conservative management as a first-line therapy. However, there was no consistent consensus on this issue due to variations in stimulation parameters、adjuvant concurrent modality or duration of treatment course, and insufficient result about large and long term follow up of randomized- controlled studies. Therefore, the investigators try to conduct one randomized-controlled trial to evaluate the efficacy of conservative treatment for Pelvic floor disorder (Pelvic organ prolapse, urinary incontinence, chronic pelvic pain etc.). At the aspect of Quality of life, our studies tried to focus on the different domains of pelvic disorder and sexual quality by means of validated questionnaire more objectively.

NCT ID: NCT02178735 Completed - Clinical trials for Pelvic Organ Prolapse

Clinical Outcomes and Urodynamic Effects After Vaginal Tailored Mesh Surgery for Pelvic Organ Prolapse

Start date: May 2014
Phase: Phase 4
Study type: Interventional

To evaluate the clinical outcome and urodynamic effect of two novel vaginal tailored mesh surgeries.

NCT ID: NCT02165280 Completed - Clinical trials for Pelvic Organ Prolapse

Guided IMagery and Patient Satisfaction (GIMPS) Following Urogynecological Surgery

GIMPS
Start date: June 2014
Phase: N/A
Study type: Interventional

We hypothesize that women who use GIM pre-operatively will feel more prepared for surgery, have less anxiety on the day of surgery and have higher satisfaction scores 6 weeks after surgery compared to women who undergo our routine pre-operative care.

NCT ID: NCT02162628 Terminated - Clinical trials for Pelvic Organ Prolapse

Exair® Versus Native Tissue Repair for Prolapse

Start date: August 2014
Phase: N/A
Study type: Observational

The purpose of this study is to compare safety and effectiveness of the Exair Prolapse Repair System for treatment of pelvic organ prolapse to traditional native tissue repair through 36 months of follow-up.

NCT ID: NCT02162615 Completed - Clinical trials for Pelvic Organ Prolapse

Restorelle® Mesh Versus Native Tissue Repair for Prolapse

Start date: August 2014
Phase:
Study type: Observational

The purpose of this study is to collect information on the safety and effectiveness of Restorelle Direct Fix mesh and the surgical procedure to implant Restorelle. These results will be compared to the safety and effectiveness results in patients who have native tissue repair (without mesh) as their pelvic organ prolapse treatment.

NCT ID: NCT02155738 Completed - Clinical trials for Pelvic Organ Prolapse

IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair

Start date: July 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether preoperative IV Acetaminophen reduces postoperative pain and narcotic consumption in women undergoing surgical repair of pelvic organ prolapse.

NCT ID: NCT02138487 Completed - Clinical trials for Pelvic Organ Prolapse

Restricted Convalescence: Outcomes Following Urogynecologic Procedures

ReCOUP
Start date: August 2014
Phase: N/A
Study type: Interventional

The investigators are conducting a study to better understand the relationship between activity restrictions and women's satisfaction following urogynecologic surgery for prolapse. We hypothesize that women with less stringent postoperative restrictions will have higher levels of satisfaction 12 weeks following surgery with no difference in respect to anatomic outcome.

NCT ID: NCT02123992 Terminated - Clinical trials for Pelvic Organ Prolapse

Study of the Elevate Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse

Harmony 522
Start date: April 2014
Phase: Phase 4
Study type: Interventional

The aim of this study is to further evaluate the safety and efficacy of the Elevate® Apical and Posterior Prolapse Repair System for repair of apical/posterior pelvic organ prolapse in a controlled, post-market cohort study.